메뉴 건너뛰기




Volumn 27, Issue 9, 2003, Pages 759-764

Use of calcimimetics in uremic patients with secondary hyperparathyroidism: Review

Author keywords

Calcimimetics; Calcium sensing receptor; Hypocalcemia; Parathyroid hormone; Renal osteodystrophy; Secondary hyperparathyroidism

Indexed keywords

BIOCHEMISTRY; METABOLISM; PHOSPHORUS; PHYSIOLOGY;

EID: 0043236409     PISSN: 0160564X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1525-1594.2003.07262.x     Document Type: Review
Times cited : (15)

References (41)
  • 1
    • 0031756899 scopus 로고    scopus 로고
    • New concepts in renal osteodystrophy
    • Hruska K. New concepts in renal osteodystrophy. Nephrol Dial Transplant 1998;13:2755-60.
    • (1998) Nephrol Dial Transplant , vol.13 , pp. 2755-2760
    • Hruska, K.1
  • 2
    • 0027485515 scopus 로고
    • Aplastic osteodystrophy without aluminum: The role of "suppressed" parathyroid function
    • Hercz G, Pei Y, Greenwood C, et al. Aplastic osteodystrophy without aluminum: the role of "suppressed" parathyroid function. Kidney Int 1993;44:860-6.
    • (1993) Kidney Int , vol.44 , pp. 860-866
    • Hercz, G.1    Pei, Y.2    Greenwood, C.3
  • 4
    • 0026936519 scopus 로고
    • Short and long-term efficacy of total parathyroidectomy with immediate autografting compared with subtotal parathyroidectomy in hemodialysis patients
    • Gagné ER, Ureña P, Leite-Silva S, et al. Short and long-term efficacy of total parathyroidectomy with immediate autografting compared with subtotal parathyroidectomy in hemodialysis patients. J Am Soc Nephrol 1992;3:1008-17.
    • (1992) J Am Soc Nephrol , vol.3 , pp. 1008-1017
    • Gagné, E.R.1    Ureña, P.2    Leite-Silva, S.3
  • 5
    • 0000795191 scopus 로고    scopus 로고
    • Single doses of the calcimimetic AMG-073 reduce parathyroid hormone levels in a dose-dependent manner in hemodialysis patients with secondary hyperparathyroidism
    • Coburn J, Barri Y, Turner S, et al. Single doses of the calcimimetic AMG-073 reduce parathyroid hormone levels in a dose-dependent manner in hemodialysis patients with secondary hyperparathyroidism. J Am Soc Nephrol 2000;11:573A.
    • (2000) J Am Soc Nephrol , vol.11
    • Coburn, J.1    Barri, Y.2    Turner, S.3
  • 6
    • 0032516837 scopus 로고    scopus 로고
    • Protein kinase C phosphorylation of threonine at position 888 in Ca2+-sensing receptor (CaR) inhibits coupling to Ca2+ store release
    • Bai M, Trivedi S, Lane CR, Yang Y, Quinn SJ, Brown EM. Protein kinase C phosphorylation of threonine at position 888 in Ca2+-sensing receptor (CaR) inhibits coupling to Ca2+ store release. J Biol Chem 1998;273:21267-75.
    • (1998) J Biol Chem , vol.273 , pp. 21267-21275
    • Bai, M.1    Trivedi, S.2    Lane, C.R.3    Yang, Y.4    Quinn, S.J.5    Brown, E.M.6
  • 7
    • 0036411684 scopus 로고    scopus 로고
    • Treatment of secondary hyperparathyroidism with vitamin D derivatives and calcimimetics before and after start of dialysis
    • Drueke TB. Treatment of secondary hyperparathyroidism with vitamin D derivatives and calcimimetics before and after start of dialysis. Nephrol Dial Transplant 2002;17(suppl 11):20-2.
    • (2002) Nephrol Dial Transplant , vol.17 , Issue.11 SUPPL. , pp. 20-22
    • Drueke, T.B.1
  • 8
    • 0027765508 scopus 로고
    • Cloning and characterization of an extracellular Ca(2+)-sensing receptor from bovine parathyroid
    • Brown EM, Gamba G, Riccardi D, et al. Cloning and characterization of an extracellular Ca(2+)-sensing receptor from bovine parathyroid. Nature 1993;366:575-80.
    • (1993) Nature , vol.366 , pp. 575-580
    • Brown, E.M.1    Gamba, G.2    Riccardi, D.3
  • 9
    • 0028946265 scopus 로고
    • Monoclonality of parathyroid tumors in chronic renal failure and in primary parathyroid hyperplasia
    • Arnold A, Brown M, Ureña P, Gaz R, Sarfati E, Drüeke T, Monoclonality of parathyroid tumors in chronic renal failure and in primary parathyroid hyperplasia. J Clin Invest 1995;95:2047-54.
    • (1995) J Clin Invest , vol.95 , pp. 2047-2054
    • Arnold, A.1    Brown, M.2    Ureña, P.3    Gaz, R.4    Sarfati, E.5    Drüeke, T.6
  • 10
    • 0032985183 scopus 로고    scopus 로고
    • The calcimimetic NPS R-568 decreases plasma PTH in rats with mild and severe renal or dietary secondary hyperparathyroidism
    • Fox J, Lowe SH, Conklin RL, Nemeth EF. The calcimimetic NPS R-568 decreases plasma PTH in rats with mild and severe renal or dietary secondary hyperparathyroidism. Endocrine 1999;10:97-103.
    • (1999) Endocrine , vol.10 , pp. 97-103
    • Fox, J.1    Lowe, S.H.2    Conklin, R.L.3    Nemeth, E.F.4
  • 11
    • 0033175760 scopus 로고    scopus 로고
    • Structure and function of the extracellular calcium-sensing receptor
    • Bai M. Structure and function of the extracellular calcium-sensing receptor (Review). Int J Mol Med 1999;4:115-25.
    • (1999) Int J Mol Med , vol.4 , pp. 115-125
    • Bai, M.1
  • 12
    • 0032483541 scopus 로고    scopus 로고
    • Dimerization of the extracellular calcium-sensing receptor (CaR) on the cell surface of CaR-transfected HEK293 cells
    • Bai M, Trivedi S, Brown EM. Dimerization of the extracellular calcium-sensing receptor (CaR) on the cell surface of CaR-transfected HEK293 cells. J Biol Chem 1998;273:23605-10.
    • (1998) J Biol Chem , vol.273 , pp. 23605-23610
    • Bai, M.1    Trivedi, S.2    Brown, E.M.3
  • 13
    • 0032987986 scopus 로고    scopus 로고
    • Extracellular "calcistat" in health and disease
    • Pearce S. Extracellular "calcistat" in health and disease. Lancet 1999;353:83-4.
    • (1999) Lancet , vol.353 , pp. 83-84
    • Pearce, S.1
  • 14
    • 0032982710 scopus 로고    scopus 로고
    • No evidence for mutations in the calcium-sensing receptor gene in sporadic parathyroid adenomas
    • Cetani F, Pinchera A, Pardi E, et al. No evidence for mutations in the calcium-sensing receptor gene in sporadic parathyroid adenomas. J Bone Miner Res 1999;14:878-82.
    • (1999) J Bone Miner Res , vol.14 , pp. 878-882
    • Cetani, F.1    Pinchera, A.2    Pardi, E.3
  • 15
    • 0028826364 scopus 로고
    • Mutational analysis of the extracellular Ca2+-sensing receptor gene in human parathyroid tumors
    • Hosokawa Y, Pollak M, Brown E, Arnold A. Mutational analysis of the extracellular Ca2+-sensing receptor gene in human parathyroid tumors. J Clin Endocrinol Metab 1995;80:3107-10.
    • (1995) J Clin Endocrinol Metab , vol.80 , pp. 3107-3110
    • Hosokawa, Y.1    Pollak, M.2    Brown, E.3    Arnold, A.4
  • 16
    • 0031042732 scopus 로고    scopus 로고
    • Depressed expression of calcium receptor in parathyroid gland tissue of patients with hyperparathyroidism
    • Gogusev J, Duchambon P, Hory B, et al. Depressed expression of calcium receptor in parathyroid gland tissue of patients with hyperparathyroidism. Kidney Int 1997;51:328-36.
    • (1997) Kidney Int , vol.51 , pp. 328-336
    • Gogusev, J.1    Duchambon, P.2    Hory, B.3
  • 17
    • 0029873489 scopus 로고    scopus 로고
    • Reduced immunostaining for the extracellular Ca2+-sensing receptor in primary and uremic secondary hyperparathyroidism
    • Kifor O, Moore F, Wang P, et al. Reduced immunostaining for the extracellular Ca2+-sensing receptor in primary and uremic secondary hyperparathyroidism. J Clin Endocrinol Metab 1996;81:1598-606.
    • (1996) J Clin Endocrinol Metab , vol.81 , pp. 1598-1606
    • Kifor, O.1    Moore, F.2    Wang, P.3
  • 18
    • 0034783848 scopus 로고    scopus 로고
    • Heterogeneous expression of receptor mRNAs in parathyroid glands of secondary hyperparathyroidism
    • Valimaki S, Farnebo F, Forsberg L, Larsson C, Farnebo LO. Heterogeneous expression of receptor mRNAs in parathyroid glands of secondary hyperparathyroidism. Kidney Int 2001;60:1666-75.
    • (2001) Kidney Int , vol.60 , pp. 1666-1675
    • Valimaki, S.1    Farnebo, F.2    Forsberg, L.3    Larsson, C.4    Farnebo, L.O.5
  • 19
    • 0036895625 scopus 로고    scopus 로고
    • Reversal of secondary hyperparathyroidism by phosphate restriction restores parathyroid calcium-sensing receptor expression and function
    • Ritter CS, Martin DR, Yan L, Slatopolsky EA, Brown AJ. Reversal of secondary hyperparathyroidism by phosphate restriction restores parathyroid calcium-sensing receptor expression and function. J Bone Min Res 2002;17:2206-13.
    • (2002) J Bone Min Res , vol.17 , pp. 2206-2213
    • Ritter, C.S.1    Martin, D.R.2    Yan, L.3    Slatopolsky, E.A.4    Brown, A.J.5
  • 20
    • 0036066178 scopus 로고    scopus 로고
    • Persistent downregulation of calcium-sensing receptor mRNA in rat parathyroids when severe secondary hyperparathyroidism is reversed by an isogenic kidney transplantation
    • Lewin E, Garfia B, Recio FL, Rodriguez M, Olgaard K. Persistent downregulation of calcium-sensing receptor mRNA in rat parathyroids when severe secondary hyperparathyroidism is reversed by an isogenic kidney transplantation. J Am Soc Nephrol 2002;13:2110-6.
    • (2002) J Am Soc Nephrol , vol.13 , pp. 2110-2116
    • Lewin, E.1    Garfia, B.2    Recio, F.L.3    Rodriguez, M.4    Olgaard, K.5
  • 21
    • 0035860795 scopus 로고    scopus 로고
    • Interaction of the calcium-sensing receptor and filamin, a potential scaffolding protein
    • Awata H, Huang C, Handlogten ME, Miller RT. Interaction of the calcium-sensing receptor and filamin, a potential scaffolding protein. J Biol Chem 2001;276:34871-9.
    • (2001) J Biol Chem , vol.276 , pp. 34871-34879
    • Awata, H.1    Huang, C.2    Handlogten, M.E.3    Miller, R.T.4
  • 22
    • 0031595986 scopus 로고    scopus 로고
    • Allosteric activation of the Ca2+ receptor in Xenopus laevis oocytes by NPS 467 or NPS 568
    • Hammerland L, Garrett J, Hung B, Levinthal C, Nemeth E. Allosteric activation of the Ca2+ receptor in Xenopus laevis oocytes by NPS 467 or NPS 568. Mol Pharmacol 1998;53:1083-8.
    • (1998) Mol Pharmacol , vol.53 , pp. 1083-1088
    • Hammerland, L.1    Garrett, J.2    Hung, B.3    Levinthal, C.4    Nemeth, E.5
  • 23
    • 0037166287 scopus 로고    scopus 로고
    • Evidence for distinct cation and calcimimetic compound (NPS 568) recognition domains in the transmembrane regions of the human Ca2+ receptor
    • Ray K, Northup J. Evidence for distinct cation and calcimimetic compound (NPS 568) recognition domains in the transmembrane regions of the human Ca2+ receptor. J Biol Chem 2002;277:18908-13.
    • (2002) J Biol Chem , vol.277 , pp. 18908-18913
    • Ray, K.1    Northup, J.2
  • 24
    • 0034012178 scopus 로고    scopus 로고
    • Activation of the calcium receptor by a calcimimetic compound halts the progression of secondary hyperparathyroidism in uremic rats
    • Chin J, Miller SC, Wada M, Nagano N, Nemeth EF, Fox J. Activation of the calcium receptor by a calcimimetic compound halts the progression of secondary hyperparathyroidism in uremic rats. J Am Soc Nephrol 2000;11:903-11.
    • (2000) J Am Soc Nephrol , vol.11 , pp. 903-911
    • Chin, J.1    Miller, S.C.2    Wada, M.3    Nagano, N.4    Nemeth, E.F.5    Fox, J.6
  • 25
    • 0033962371 scopus 로고    scopus 로고
    • Daily intermittent decreases in serum leveis of parathyroid hormone have an anabolic-like action on the bones of uremic rats with low-turnover bone and osteomalacia
    • Ishii H, Wada M, Furuya Y, Nagano N, Nemeth EF, Fox J. Daily intermittent decreases in serum leveis of parathyroid hormone have an anabolic-like action on the bones of uremic rats with low-turnover bone and osteomalacia. Bone 2000;26:175-82.
    • (2000) Bone , vol.26 , pp. 175-182
    • Ishii, H.1    Wada, M.2    Furuya, Y.3    Nagano, N.4    Nemeth, E.F.5    Fox, J.6
  • 26
    • 0031888842 scopus 로고    scopus 로고
    • A calcimimetic agent acutely suppresses parathyroid hormone levels in patients with chronic renal failure. Rapid communication
    • Antonsen JE, Sherrard DJ, Andress DL. A calcimimetic agent acutely suppresses parathyroid hormone levels in patients with chronic renal failure. Rapid communication. Kidney Int 1998;53:223-7.
    • (1998) Kidney Int , vol.53 , pp. 223-227
    • Antonsen, J.E.1    Sherrard, D.J.2    Andress, D.L.3
  • 27
    • 0031466527 scopus 로고    scopus 로고
    • The calcimimetic compound NPS R-568 suppresses parathyroid cell proliferation in rats with renal insufficiency. Control of parathyroid cell growth via a calcium receptor
    • Wada M, Furuya Y, Sakiyama J, et al. The calcimimetic compound NPS R-568 suppresses parathyroid cell proliferation in rats with renal insufficiency. Control of parathyroid cell growth via a calcium receptor. J Clin Invest 1997;100:2977-83.
    • (1997) J Clin Invest , vol.100 , pp. 2977-2983
    • Wada, M.1    Furuya, Y.2    Sakiyama, J.3
  • 29
    • 0032892011 scopus 로고    scopus 로고
    • Mixed-effects modeling of the pharmacodynamic response to the calcimimetic agent R-568
    • Lalonde RL, Gaudreault J, Karhu DA, Marriott TB. Mixed-effects modeling of the pharmacodynamic response to the calcimimetic agent R-568. Clin Pharmacol Ther 1999;65:40-9.
    • (1999) Clin Pharmacol Ther , vol.65 , pp. 40-49
    • Lalonde, R.L.1    Gaudreault, J.2    Karhu, D.A.3    Marriott, T.B.4
  • 30
    • 0030667380 scopus 로고    scopus 로고
    • Short-term inhibition of parathyroid hormone secretion by a calcium-receptor agonist in patients with primary hyperparathyroidism
    • Silverberg SJ, Bone HG, III, Marriott TB, et al. Short-term inhibition of parathyroid hormone secretion by a calcium-receptor agonist in patients with primary hyperparathyroidism. N Engl J Med 1997;337:1506-10.
    • (1997) N Engl J Med , vol.337 , pp. 1506-1510
    • Silverberg, S.J.1    Bone H.G. III2    Marriott, T.B.3
  • 32
    • 0036208986 scopus 로고    scopus 로고
    • The calcimimetic agent AMG 073 lowers plasma parathyroid hormone levels in hemodialysis patients with secondary hyperparathyroidism
    • Goodman WG, Hladik GA, Turner SA, et al. The calcimimetic agent AMG 073 lowers plasma parathyroid hormone levels in hemodialysis patients with secondary hyperparathyroidism. J Am Soc Nephrol 2002;13:1017-24.
    • (2002) J Am Soc Nephrol , vol.13 , pp. 1017-1024
    • Goodman, W.G.1    Hladik, G.A.2    Turner, S.A.3
  • 33
    • 6444245707 scopus 로고    scopus 로고
    • The calcimimetic AMG-073 reduces parathyroid hormone (PTH), phosphorus, and calcium x phosphorus product in secondary hyperparathyroidism
    • Lindberg J, Moe S, Goodman W, et al. The calcimimetic AMG-073 reduces parathyroid hormone (PTH), phosphorus, and calcium x phosphorus product in secondary hyperparathyroidism. J Am Soc Nephrol 2002;63:248-54.
    • (2002) J Am Soc Nephrol , vol.63 , pp. 248-254
    • Lindberg, J.1    Moe, S.2    Goodman, W.3
  • 34
    • 0011866033 scopus 로고    scopus 로고
    • The calcimimetic AMG 073 reduces PTH and Ca x P in patients with secondary hyperparathyroidism (SHPT)
    • Quarles LD, Sherrard DJ, Adler S, et al. The calcimimetic AMG 073 reduces PTH and Ca x P in patients with secondary hyperparathyroidism (SHPT). J Am Soc Nephrol 2001;12:771A.
    • (2001) J Am Soc Nephrol , vol.12
    • Quarles, L.D.1    Sherrard, D.J.2    Adler, S.3
  • 35
    • 0041436109 scopus 로고    scopus 로고
    • The calcimimetic AMG-073: A potential novel therapy for secondary hyperparathyroidism (SHPT)
    • Block G, Coyne D, Goodman W, et al. The calcimimetic AMG-073: A potential novel therapy for secondary hyperparathyroidism (SHPT). J Am Soc Nephrol 2002;13:572A.
    • (2002) J Am Soc Nephrol , vol.13
    • Block, G.1    Coyne, D.2    Goodman, W.3
  • 36
    • 0042939223 scopus 로고    scopus 로고
    • Two-year treatment with the calcimimetic AMG-073 in hemodialysis patients with secondary hyperparathyroidism (SHPT)
    • Moe S, Sprague S, Adler S, et al. Two-year treatment with the calcimimetic AMG-073 in hemodialysis patients with secondary hyperparathyroidism (SHPT). J Am Soc Nephrol 2002;13:572A.
    • (2002) J Am Soc Nephrol , vol.13
    • Moe, S.1    Sprague, S.2    Adler, S.3
  • 37
    • 0042939223 scopus 로고    scopus 로고
    • The effects of one-year treatment with the calcimimetic AMG-073 on bone health in ESRD patients with secondary hyperparathyroidism (SHPT)
    • Quarles L, Spiegel D, Curzi M, et al. The effects of one-year treatment with the calcimimetic AMG-073 on bone health in ESRD patients with secondary hyperparathyroidism (SHPT). J Am Soc Nephrol 2002;13:572A-3A.
    • (2002) J Am Soc Nephrol , vol.13
    • Quarles, L.1    Spiegel, D.2    Curzi, M.3
  • 38
    • 0041436108 scopus 로고    scopus 로고
    • Self-reported cognitive functioning in hemodialysis patients with secondary HPT: The effect of the calcimimetic AMG-073
    • Chertow G, Danese M, McCary L, Turner S. Self-reported cognitive functioning in hemodialysis patients with secondary HPT: The effect of the calcimimetic AMG-073. J Am Soc Nephrol 2002;13:633A.
    • (2002) J Am Soc Nephrol , vol.13
    • Chertow, G.1    Danese, M.2    McCary, L.3    Turner, S.4
  • 39
    • 26344440615 scopus 로고    scopus 로고
    • The SF-36 scales and the KDQOL cognitive functioning scale are reliable, valid and responsive in hemodialysis patients with secondary hyperparathyroidism
    • Lindberg J, Danese M, Spiegel D, Thezan G, Blaisdell P, Turner S. The SF-36 scales and the KDQOL cognitive functioning scale are reliable, valid and responsive in hemodialysis patients with secondary hyperparathyroidism. J Am Soc Nephrol 2002;13:702A.
    • (2002) J Am Soc Nephrol , vol.13
    • Lindberg, J.1    Danese, M.2    Spiegel, D.3    Thezan, G.4    Blaisdell, P.5    Turner, S.6
  • 40
    • 0036089693 scopus 로고    scopus 로고
    • Glandes parathyroïdes, récepteur du calcium et calcimimétiques
    • Ureña P. Glandes parathyroïdes, récepteur du calcium et calcimimétiques. Néphrologie 2002;23:151-64.
    • (2002) Néphrologie , vol.23 , pp. 151-164
    • Ureña, P.1
  • 41
    • 0035129796 scopus 로고    scopus 로고
    • Prevention of uremic bone disease using calcimimetic compounds
    • Olgaard K, Lewin E. Prevention of uremic bone disease using calcimimetic compounds. Annu Rev Med 2001;52:203-20.
    • (2001) Annu Rev Med , vol.52 , pp. 203-220
    • Olgaard, K.1    Lewin, E.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.